Martin Zentgraf
Chief Executive Officer at Desitin Arzneimittel GmbH
Profile
Martin Zentgraf currently works at Desitin Arzneimittel GmbH, as Managing Director and Bourne Capital Partners LLC (Private Equity), as Senior Advisor from 2022.
Dr. Zentgraf received his graduate degree in 1985 from the University of Münster.
Martin Zentgraf active positions
| Companies | Position | Start |
|---|---|---|
Desitin Arzneimittel GmbH
 Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Chief Executive Officer | 09/10/2011 |
Bourne Capital Partners LLC (Private Equity)
 Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Consultant / Advisor | 31/12/2021 |
Training of Martin Zentgraf
| University of Münster | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Desitin Arzneimittel GmbH
Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Health Technology |
Bourne Capital Partners LLC (Private Equity)
Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Finance |
- Stock Market
- Insiders
- Martin Zentgraf
